October 24, 2011 (Boston, Massachusetts) — Injecting a lower dose of 2010/11 trivalent influenza vaccine (TIV) intradermally was more immunogenic than a traditional full-dose intramuscular injection ...
If found to be safe and immunogenic, reduced doses of influenza vaccine given by the intradermal route could increase the number of available doses of vaccine. In an open-label study, we randomly ...
The loss of half the U.S. supply of influenza vaccine due to contamination has created a critical shortage. Dose-sparing strategies that use intradermal delivery of vaccines may be one approach to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results